Korean chaebol SK Group buys nearly 25% drug maker Imexpharm’s stake
The third-largest conglomerate in South Korea has purchased 24.9% stake, or 12.3 million shares of Imexpharm, according to data from Vietnam Securities Depository.
The third-largest conglomerate in South Korea has purchased 24.9% stake, or 12.3 million shares of Imexpharm, according to data from Vietnam Securities Depository.